The Importance of LDL-C Lowering with Evolocumab in Recent ACS
[Speaker] 서정원/서울의대
PCSK9 Inhibition: Beyond LDL-C Lowering Effect in ACS Patients
[Speaker] 정영훈/경상의대
Discussion